Analystreport

REDHILL BIOPHAR/S (NASDAQ: RDHL) had its price target lowered by analysts at Roth Capital from to .

Redhill Biopharma Ltd. - American Depositary Shares  (RDHL) 
US:NASDAQ Investor Relations: ir.redhillbio.com/investor-relations